Open AccessWhat is The Case of More Accessible Treatment Options in COVID 19: Comparison of Hydroxychloroquine and Favipiravir Based on Laboratory Values?
Author(s) -
Buket Mermi̇̇t Çi̇̇li̇̇ngi̇̇r,
Aysel Sunnetcioglu,
Hanifi Yıldız,
Berrak Mermit Erçek,
Nuruban Delal Baykal
Publication year - 2021
Publication title -
eastern journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.123
H-Index - 10
eISSN - 1309-3886
pISSN - 1301-0883
DOI - 10.5505/ejm.2021.46548
Subject(s) - favipiravir , medicine , hydroxychloroquine , pneumonia , covid-19 , gastroenterology , disease , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom